Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage: A hospital-based linkage study

Internal Medicine Journal

Volumn 45, Issue 1, 2015, Pages 48-54

  Huang, Y ^a,b   de Boer, W B ^c   Adams, L A ^a,b   Macquillan, G ^a,b   Bulsara, M K ^d   Jeffrey, G P ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

^d UNIVERSITY OF NOTRE DAME   (Australia)

Author keywords

Decompensation; Hepatitis C; Hepatocellular carcinoma; Liver fibrosis; Liver related death

Indexed keywords

ADULT; ARTICLE; DEATH; DECOMPENSATED LIVER CIRRHOSIS; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE; AGED; AUSTRALIA; BIOPSY; CARCINOMA, HEPATOCELLULAR; COMPLICATION; DISEASE COURSE; FOLLOW UP; HEPATITIS C, CHRONIC; HOSPITAL; INCIDENCE; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HOSPITALS; HUMANS; INCIDENCE; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; WESTERN AUSTRALIA;

EID: 84920997445     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12626     Document Type: Article

References (27)

1. Jacobson IM, Davis GL, El-Serag H, Negro F, Trepo C. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol 2010; 8: 924-933, quiz e117.
2. Neal KR, Ramsay S, Thomson BJ, Irving WL. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study. Gut 2007; 56: 1098-1104.
3. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006; 368: 938-945.
4. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001; 34: 730-739.
5. Di Martino V, Crouzet J, Hillon P, Thevenot T, Minello A, Monnet E. Long-term outcome of chronic hepatitis C in a population-based cohort and impact of antiviral therapy: a propensity-adjusted analysis. J Viral Hepat 2011; 18: 493-505.
6. Wiley TE, Brown J, Chan J. Hepatitis C infection in African Americans: its natural history and histological progression. Am J Gastroenterol 2002; 97: 700-706.
7. Wiese M, Grungreiff K, Guthoff W, Lafrenz M, Oesen U, Porst H. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany - a 25-year multicenter study. J Hepatol 2005; 43: 590-598.
8. Ferenci P, Ferenci S, Datz C, Rezman I, Oberaigner W, Strauss R. Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s. J Hepatol 2007; 47: 31-36.
9. Holman CD, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 1999; 23: 453-459.
10. Freemantle CJ, Read AW, de Klerk NH, McAullay D, Anderson IP, Stanley FJ. Patterns, trends, and increasing disparities in mortality for Aboriginal and non-Aboriginal infants born in Western Australia, 1980-2001: population database study. Lancet 2006; 367: 1758-1766.
11. Hansen M, Kurinczuk JJ, Bower C, Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med 2002; 346: 725-730.
12. Gillett M, Davis WA, Jackson D, Bruce DG, Davis TM. Prospective evaluation of carotid bruit as a predictor of first stroke in type 2 diabetes: the Fremantle Diabetes Study. Stroke 2003; 34: 2145-2151.
13. Everhart JE, Wright EC, Goodman ZD, Dienstag JL, Hoefs JC, Kleiner DE etal. Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 2010; 51: 585-594.
14. Lawson A, Hagan S, Rye K, Taguri N, Ratib S, Zaitoun AM etal. The natural history of hepatitis C with severe hepatic fibrosis. J Hepatol 2007; 47: 37-45.
15. Parkes J, Roderick P, Harris S, Day C, Mutimer D, Collier J etal. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut 2010; 59: 1245-1251.
16. Ngo Y, Munteanu M, Messous D, Charlotte F, Imbert-Bismut F, Thabut D etal. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 2006; 52: 1887-1896.
17. Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B, Merrouche W etal. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011; 140: 1970-1979. 79 e1-3.
18. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011; 55: 245-264.
19. Omata M, Kanda T, Yu M-L, Yokosuk O, Lim S-G, Jafri W etal. APASL consensus statements and management algorithms for hepatitis C virus infection. Hepatol Int 2012; 6: 409-435.
20. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374.
21. Australian Government Department of Health. Section 100 - Highly Specialised Drugs Program. [cited 2014 Jun]. Available from URL: http://www.pbs.gov.au/info/browse/section-100/s100-highly-specialised-drugs
22. Thein HH, Yi Q, Dore GJ, Krahn MD. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology 2008; 48: 418-431.
23. Yi Q, Wang PP, Krahn M. Improving the accuracy of long-term prognostic estimates in hepatitis C virus infection. J Viral Hepat 2004; 11: 166-174.
24. Alazawi W, Cunningham M, Dearden J, Foster GR. Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection. Aliment Pharmacol Ther 2010; 32: 344-355.
25. Sangiovanni A, Prati GM, Fasani P, Ronchi G, Romeo R, Manini M etal. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 2006; 43: 1303-1310.
26. D'Amico G, Morabito A, Pagliaro L, Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468-475.
27. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-231.